Skip to main content

Monique Bennett

By

Monique Bennett has been a scientist for 10 years, with specific experience in antibody discovery, vaccine science, and infectious disease. She graduated with her Master’s Degree from the College of William and Mary in Cellular and Molecular Biology before obtaining a PhD in Microbiology at Vanderbilt University Medical Center in Nashville, TN. She next worked as a Research Assistant Professor, performing clinical research targeted towards producing new vaccine targets and therapeutics for bacterial pathogens.

Richard Bendis

By

Rich Bendis is the Founder, President, and CEO of BioHealth Innovation, Inc. (BHI), a public-private nonprofit based in the BioHealth Capital Region (Maryland/DC/Virginia), focused on accelerating the biohealth industry nationally and internationally. A recognized leader in the global innovation economy, Rich was also the founding President and CEO of Innovation America, a national partnership driving the growth of innovation across the U.S.

His career spans roles as a successful entrepreneur, corporate executive, venture capitalist, angel investor, investment banker, and an expert in technology-based economic development. Rich has served on numerous prestigious boards and advisory groups, including the White House U.S. Innovation Partnership Advisory Task Force, the National Association of State Venture Funds, and the Small Business Innovation Research Committee. He was also a founding Chairman of The Kansas Technology Enterprise Corporation and the Founder and CEO of Innovation Philadelphia. Internationally, he has provided global consulting services to over 16 countries and 22 states, several cities and regions, along with international organizations including the United Nations, NATO, UK Trade and Industry, European Commission, French Embassy, the German Marshall Fund, The Canadian Consulate, METI, AKEA, the International Science Parks and Innovation Expert Group and other global entities. Previously, Mr. Bendis successfully leveraged a career in the private sector (with Quaker Oats, Polaroid, Texas Instruments, Marion Laboratories and Kimberly Services) and the venture capital industry (RAB Ventures). Mr. Bendis also successfully built an Inc. 500 healthcare software company, Continental Healthcare Systems, Inc., which he took public on NASDAQ and later sold to an international conglomerate.

In addition, Mr. Bendis continues to be an active investor. In Maryland, Rich sits on Governor Moore’s Life Science Advisory Board and is Co-Chair of the AURP BioHealth Caucus. Known for his contributions to the innovation sector, he has been recognized as a Top 5 Speaker on innovation, one of Maryland’s most influential leaders, and the host of the BioTalk podcast. He was voted one of the Top 5 Speakers on innovation and creativity, voted 4th best Innovation Blogger, a most influential Marylander award and a Maryland innovator of the year award.

Renée JG Arnold, PharmD, RPh

By

Renée JG Arnold is currently President & CEO, Arnold Consultancy & Technology, LLC, where she oversees outcomes research and develops affiliated software for pharmaceutical and government programs. Her special interest in evidence-based health derives from her research that deals with use of technology to collect and/or model real-world data for use in rational decision-making by healthcare practitioners and policy makers. She is also Adjunct Professor, Master of Public Health program, Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai, New York, New York, where she has developed and teaches the pharmacoeconomics coursework. Dr. Arnold completed her undergraduate training at the University of Maryland and received her Doctor of Pharmacy degree from the University of Southern California in Los Angeles. She also completed a post-doctoral residency at University Hospital in San Diego/University of California at San Francisco School of Pharmacy. Dr. Arnold is a founding member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is the Chair of multiple special interest groups (SIGS) there including, most recently, the Open Source Model SIG. Dr. Arnold is an author of numerous articles, book chapters and books in the areas of pharmacology, pharmacoeconomics and cost containment strategies and recently published the 2nd edition of her pharmacoeconomics textbook

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.